Literature DB >> 24091875

MYC amplification and overexpression in primary cutaneous angiosarcoma: a fluorescence in-situ hybridization and immunohistochemical study.

Wonwoo Shon1, William R Sukov1, Sarah M Jenkins2, Andrew L Folpe1.   

Abstract

MYC, a proto-oncogene located on chromosome 8q24, is involved in the control of cell proliferation and differentiation. Previous studies have documented high-level MYC gene amplification and MYC overexpression by immunohistochemistry (IHC) in post-irradiation angiosarcomas, but not in primary cutaneous angiosarcoma (AS-C) or in other radiation-associated vascular proliferations, such as atypical vascular lesions. Prompted by our recent finding of MYC amplification in a primary hepatic AS, we analyzed a large number of well-characterized AS-C for MYC amplification and protein overexpression. Formalin-fixed, paraffin-embedded blocks from 38 AS-C were retrieved from our archives and were examined by IHC analysis and fluorescence in-situ hybridization (FISH), using a commercially available antibody and probe. For FISH analysis, the number of copies of MYC was compared with the control gene, CEN8 (MYC/CEN8 ratio). All cases occurred on sun-exposed skin; no patient was known to have a history of therapeutic irradiation. Possible associations between survival and a wide variety of clinicopathological variables were evaluated using the log-rank test. By IHC analysis, MYC overexpression was present in 9/38 (24%) AS-C (2-3+: 6 cases, 16%; 1+: 3 cases, 8%). By FISH analysis, 2/5 (40%) informative cases with 2-3+ immunostaining showed high-level gene amplification. One additional case with 3+ immunostaining showed higher level aneusomy of chromosome 8 (5-8 MYC and CEN8). Two out of fourteen (14%) IHC-negative cases also carried MYC amplification (one high level and one lower level). Low copy number gain of chromosome 8 (3-5 MYC and CEN8) was observed in AS-C with or without MYC expression. MYC amplification and MYC protein overexpression were not correlated with clinical outcome. We have shown, for the first time, MYC gene amplification and protein overexpression in primary (non-radiation-associated) AS of the skin. MYC protein overexpression in cases lacking gene amplification likely reflects other mechanisms of MYC activation. The study of a larger number of AS-C showing MYC amplification may be necessary to determine whether the behavior of such cases differs from their more common non-amplified counterparts.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24091875     DOI: 10.1038/modpathol.2013.163

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  24 in total

Review 1.  What is new in endothelial neoplasia?

Authors:  David J Papke; Jason L Hornick
Journal:  Virchows Arch       Date:  2019-08-28       Impact factor: 4.064

Review 2.  [Cutaneous angiosarcoma: new aspects].

Authors:  T Brenn
Journal:  Pathologe       Date:  2015-02       Impact factor: 1.011

Review 3.  Angiosarcomas: histology, immunohistochemistry and molecular insights with implications for differential diagnosis.

Authors:  Isidro Machado; Francisco Giner; Javier Lavernia; Julia Cruz; Víctor Traves; Celia Requena; Beatriz Llombart; José Antonio López-Guerrero; Antonio Llombart-Bosch
Journal:  Histol Histopathol       Date:  2020-09-04       Impact factor: 2.303

Review 4.  Angiosarcoma: a review of diagnosis and current treatment.

Authors:  Jun Cao; Jiale Wang; Chiyu He; Meiyu Fang
Journal:  Am J Cancer Res       Date:  2019-11-01       Impact factor: 6.166

Review 5.  Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.

Authors:  Adrián Mariño-Enríquez; Judith V M G Bovée
Journal:  Surg Pathol Clin       Date:  2016-09

6.  Recurrent CIC Gene Abnormalities in Angiosarcomas: A Molecular Study of 120 Cases With Concurrent Investigation of PLCG1, KDR, MYC, and FLT4 Gene Alterations.

Authors:  Shih-Chiang Huang; Lei Zhang; Yun-Shao Sung; Chun-Liang Chen; Yu-Chien Kao; Narasimhan P Agaram; Samuel Singer; William D Tap; Sandra D'Angelo; Cristina R Antonescu
Journal:  Am J Surg Pathol       Date:  2016-05       Impact factor: 6.394

7.  MYC Analysis by Fluorescent In Situ Hybridization and Immunohistochemistry in Primary Adrenal Angiosarcoma (PAA): a Series of Four Cases.

Authors:  Kristine M Cornejo; Lloyd Hutchinson; Maryann St Cyr; Vania Nose; Patrick J McLaughlin; A John Iafrate; Peter M Sadow
Journal:  Endocr Pathol       Date:  2015-12       Impact factor: 3.943

8.  Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential.

Authors:  Ryan M Gill; Benjamin Buelow; Cheryl Mather; Nancy M Joseph; Venancio Alves; Elizabeth M Brunt; Ta-Chiang Liu; Hala Makhlouf; Celia Marginean; ILKe Nalbantoglu; Christine Sempoux; Dale C Snover; Swan N Thung; Matthew M Yeh; Linda D Ferrell
Journal:  Hum Pathol       Date:  2016-04-14       Impact factor: 3.466

9.  Reduced H3K27me3 expression in radiation-associated angiosarcoma of the breast.

Authors:  Thomas Mentzel; Katalin Kiss
Journal:  Virchows Arch       Date:  2017-10-05       Impact factor: 4.064

Review 10.  Soft Tissue Special Issue: Cutaneous Pleomorphic Spindle Cell Tumors.

Authors:  Thomas Brenn
Journal:  Head Neck Pathol       Date:  2020-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.